The Enterprise Value as of December 2025 (TTM) for Anthera Pharmaceuticals, Inc. (ANTH) is -2193382.00

According to Anthera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -2193382.00. This represents a change of -124.90% compared to the average of 8.81M of the last 4 quarters.

Anthera Pharmaceuticals, Inc. (ANTH) Historical Enterprise Value (quarterly & annually)

How has ANTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Anthera Pharmaceuticals, Inc. over the last ten years is 53.01M. The current -2193382.00 Enterprise Value has changed -513.73% with respect to the historical average. Over the past ten years (40 quarters), ANTH's Enterprise Value was at its highest in in the June 2015 quarter at 273.29M. The Enterprise Value was at its lowest in in the March 2018 quarter at -1138903.26.

Anthera Pharmaceuticals, Inc. (ANTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anthera Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anthera Pharmaceuticals, Inc. (ANTH) Average Enterprise Value

How has ANTH Enterprise Value performed in the past?

The current Enterprise Value of Anthera Pharmaceuticals, Inc. (ANTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anthera Pharmaceuticals, Inc. (ANTH) Enterprise Value vs. Peers

How is ANTH’s Enterprise Value compared to its peers?

Anthera Pharmaceuticals, Inc.’s Enterprise Value is greater than PhaseRx, Inc. (-4278831.00), less than Neurobiological Technologies, Inc. (-1839298.00), less than Synovics Pharmaceuticals, Inc. (6.49M), less than Cotinga Pharmaceuticals Inc. (-16119.00), greater than Sienna Biopharmaceuticals, Inc. (-18397909.00), less than Comera Life Sciences Holdings, Inc. (331.51K), less than SheerVision, Inc. (59.90K), greater than GlobeImmune, Inc. (-9900147.00), less than OncoVista Innovative Therapies, Inc. (198.17K), less than Viveon Health Acquisition Corp. (70.54M),

Build a custom stock screener for Anthera Pharmaceuticals, Inc. (ANTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anthera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anthera Pharmaceuticals, Inc. (ANTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anthera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.